Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+368.2%
5Y CAGR+176.7%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+368.2%/yr
vs +41.8%/yr prior
5Y CAGR
+176.7%/yr
Recent acceleration
Acceleration
+326.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
162.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 346045000.00 | +635.8% |
| 2024 | 47027638.00 | +581.9% |
| 2023 | 6897065.00 | +104.6% |
| 2022 | 3371231.00 | +28.2% |
| 2021 | 2629784.00 | +23.2% |
| 2020 | 2134869.00 | +67.0% |
| 2019 | 1277985.00 | +53.4% |
| 2018 | 832902.00 | +37.6% |
| 2017 | 605127.00 | +54.5% |
| 2016 | 391669.00 | - |